詹 超舜

Medicine & Life Sciences

1. Pulmonary Veins 100%
2. Atrial Fibrillation 99%
3. Sinoatrial Node 75%
4. Catheter Ablation 68%
5. Arrhythmogenic Right Ventricular Dysplasia 64%
6. Heart Atria 60%
7. Electrocardiography 41%
8. Cardiac Arrhythmias 38%
9. Veins 38%
10. Coronary Vessels 37%
11. Ivabradine 34%
12. Tachycardia 34%
13. Heart Failure 33%
14. Circulating MicroRNA 31%
15. 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate 30%
16. Action Potentials 29%
17. Long QT Syndrome 29%
18. Hydrogen Sulfide 29%
19. sodium bisulfide 29%
20. Atrial Flutter 28%
21. Induced Hypothermia 28%
22. Superior Vena Cava 27%
23. AMP-Activated Protein Kinases 27%
24. Vascular Stiffness 26%
25. Rabbits 26%
26. Ventricular Tachycardia 26%
27. Chloroquine 25%
28. Protein Kinase C 21%
29. Coronary Artery Disease 20%
30. Chronic Obstructive Pulmonary Disease 20%
31. Stents 19%
32. Recurrence 19%
33. Calcium 18%
34. chelerythrine 18%
35. Angiography 18%
36. Biomarkers 17%
37. Myocardial Infarction 16%
38. Temperature 16%
39. Tomography 15%
40. Ranolazine 15%
41. Polyvinyl Chloride 15%
42. Health 13%
43. Population 12%
44. Microelectrodes 11%
45. Glyburide 10%
46. Confidence Intervals 10%
47. rottlerin 10%
48. Endocardium 9%
49. MicroRNAs 9%
50. Mortality 9%